Jessica is a life science strategy consultant with versatile experience in life sciences. She focuses on technology, innovation strategy, and transactions; she has led licensing & acquisition screens, R&D prioritization strategy, technology and market assessment, as well as product life cycle innovation across multiple therapeutic areas and life science technologies. She was previously a senior consultant at Valamont Advisors, a life sciences strategy boutique firm now part of Parthenon-EY, and worked as part of Quintiles Consulting’s Portfolio Strategy and Transactions team. Prior to consulting, she was a biotechnology analyst at Syzygy Therapeutics, a biotech fund that invests in, and oversees the clinical development of, later-stage assets. Jessica completed four years of neuroscience research at Princeton and Rockefeller Universities after earning a B.Sc in Biology from Princeton University.